tert-butyl 3-fluoroazetidine-1-carboxylate

Details:

Founded in Mar. 2012,?Shenzhen InnoSyn Biotech Co., Ltd.?is a National High-tech Enterprise which engages in R&D, manufacturing and sales of novel API, intermediate, fine chemical, as well as derivatives of chiral compounds and high value-added amino acid... Running by experienced R&D team, overseas returnees and senior managements, InnoSyn get powerful technical superiority in the innovative product's development and accumulated rich experience in company's management.
R&D

Well equipped with hardware, talents and intellectual property: 4000+ m2?R&D center, tens of technicians, 4 Invention patents, sufficient test equipments... InnoSyn has brilliant innovative ability and is able to offer customers all kinds of solution on new product development, production, test as well as professional service like CRO, FTE/FFS, CDMO etc.

Featured Technology
Chiral technology
Couping technology
Fluoridation technology
Grignard Reaction

Production Facility

The 47,000m2?branded new?production facility locates in Wuhua county, Meizhou Guangdong, 240km to Shenzhen Yantian Seaport.?

Project I
3 workshops (8400m2), including 1 Hydrogenation workshop;
18 Reactors (including 4 hydrogenation reactors), from 500L to 5000L;
Reaction temperature: -20 °C to 250 °C
Pressure scope for hydrogenation: maximum to 840 psi (~70kg)?
Production Capacity: 100kg to 1,024 Ton
Project II
Under planned...
Currently InnoSyn is investing more to expand international sales and expecting similar success as domestic market. We are ready to cooperate with more customers from abroad and hopefully achieve win-win development with all friends, we do wish InnoSyn will be your best partner and friend in China!